Global X Genomics & Biotechnology ETF

Premium/discount is how far the market price trades above (+) or below (−) the fund's net asset value (reported in USD).

3-year risk statistics are not currently available for this fund.

Risk statistics are 3-year, month-end-based.

Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.

Fees & expenses

Category

Equity – SectorHealth Care

Asset class

Equity

Strategy

Passive

Themes

BiotechnologyGenomics

Sector

Health Care

Issuer

Global X Management Company LLC

Branding

Global X

Similar ETFs

Funds sharing the same category or exposures.

• IBBUS

  iShares Biotechnology ETF

  Same category · Same sector · biotechnology

  $10.64B0.440%+24.41%
• ARKGUS

  ARK Genomic Revolution ETF

  Same category · Same sector · genomics

  $2.17B0.750%+84.19%
• HELXUS

  Franklin Genomic Advancements ETF

  Same category · Same sector · genomics

  $33.20M0.500%+22.01%
• XLVUS

  State Street® Health Care Select Sector SPDR® ETF

  Same category · Same sector

  $43.92B0.080%+11.63%
• VGTUS

  Vanguard Information Technology Index Fund

  Same group

  $170.65B0.090%+34.36%
• XLKUS

  State Street® Technology Select Sector SPDR® ETF

  Same group

  $127.79B0.080%+36.81%

Frequently asked questions

What is GNOM's expense ratio?

Global X Genomics & Biotechnology ETF charges a net expense ratio of 0.500%.

How large is Global X Genomics & Biotechnology ETF?

GNOM holds $105.69M in assets under management.

What index does GNOM track?

Global X Genomics & Biotechnology ETF tracks Solactive Genomics as its primary benchmark.

When did GNOM launch?

Global X Genomics & Biotechnology ETF launched on April 5, 2019.

What currency does GNOM trade in?

GNOM trades in USD on Nasdaq - All Markets.

Fund information